<DOC>
	<DOCNO>NCT01647256</DOCNO>
	<brief_summary>The primary purpose study evaluate eat high fat meal versus eat food affect study drug ( Nikkomycin Z ) absorb body . The second purpose gain information safety Nikkomycin Z healthy adult .</brief_summary>
	<brief_title>Comparison Nikkomycin Z Bioavailability Under Fed Fasting Conditions</brief_title>
	<detailed_description>To compare single-dose bioavailability Nikkomycin Z 500 mg ( two 250 mg capsule ) feed fast condition .</detailed_description>
	<mesh_term>Nikkomycin</mesh_term>
	<criteria>Be least 18 year age 40 year age Be male , female ( non childbearing potential use adequate contraception ) Have body mass index 18 29 kg/m2 Able understand study give write informed consent Be determine healthy base medical laboratory evaluation Patients age 18 year 40 year age Current smoker history smoking within 3 month participation Inability comprehend study provide write informed consent Inability comply study requirement History current evidence major organ disease Renal disease serum creatinine &gt; 1.5 mg/dL , significant hematuria proteinuria , know structural abnormality chronic kidney disease Hepatic disease active viral hepatitis , history hepatitis B hepatitis C , bilirubin &gt; 2.0 , ALT AST normal upper limit laboratory , alcoholic liver disease , chronic liver disease CNS disease cognitive dysfunction past history epilepsy , CNS infection , stroke , CNS bleed , severe headache , major psychiatric illness , current mental status change Lung disease history severe asthma , COPD , pulmonary tuberculosis , major lung disease Cardiac disease history current evidence ischemic coronary artery disease , myocardial infarction , heart failure , significant arrhythmia Gastrointestinal disease presence inflammatory bowel disease , difficulty swallowing , gastrointestinal probably would limit take oral medication may compromise absorption oral medication Cancer History hematologic malignancy solid tumor exclude basal cell carcinoma limit skin within past 5 year History autoimmune inflammatory disease rheumatoid arthritis lupus Immunocompromised state solid organ transplant , cancer chemotherapy , stem cell transplant graft versus host disease , immunosuppressive therapy , HIV infection Recent weight loss great 10 % Any history evidence disease opinion physician would increase risk subject clinical trial participation Regular use prescription medication , overthecounter medication , dietary/herbal supplement within 14 day day 1 . Occasional use acetaminophen overthecounter NSAID within 14 day window may allow P.I . discretion Subjects receive another investigational drug within 30 day enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Bioavailability</keyword>
	<keyword>Fed</keyword>
	<keyword>Fasting</keyword>
</DOC>